The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Gene Amplification Technologies Market Research Report 2024

Global Gene Amplification Technologies Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1715882

No of Pages : 97

Ask Your Query

Synopsis

Gene amplification refers to a number of natural and artificial processes by which the number of copies of a gene is increased "without a proportional increase in other genes".

The global Gene Amplification Technologies market was valued at US$ 26150 million in 2023 and is anticipated to reach US$ 30040 million by 2030, witnessing a CAGR of 2.0% during the forecast period 2024-2030.

The Gene Amplification Technologies Market is driven by the ever-increasing demand for sophisticated and precise tools in molecular biology, genetic research, and diagnostics. Gene amplification technologies, which include polymerase chain reaction (PCR) and other molecular techniques, play a pivotal role in replicating and analyzing DNA and RNA sequences. These technologies are essential for a wide range of applications, including disease diagnosis, genetic profiling, and drug development. As research and diagnostic capabilities advance, the demand for more sensitive, rapid, and cost-effective gene amplification methods continues to grow. However, a key challenge for this market is the need to keep pace with rapidly evolving research and diagnostic requirements, as well as the increasing demand for point-of-care and resource-limited settings. Overcoming issues related to sensitivity, specificity, and scalability while adhering to regulatory and quality control standards remains an ongoing challenge. Additionally, the market faces competition from alternative genetic analysis techniques and the need for continuous innovation to address emerging genetic challenges. Striking a balance between accuracy, affordability, and adaptability to diverse applications is essential for the continued growth of the Gene Amplification Technologies Market.

This report aims to provide a comprehensive presentation of the global market for Gene Amplification Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Amplification Technologies.

Report Scope

The Gene Amplification Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Amplification Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Amplification Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  • Abbott Laboratories
  • QIAGEN
  • Agilent Technologies
  • Bayer Corporation
  • Rubicon Genomics
  • BD
  • Roche Diagnostics
  • BioMerieux
  • Bio-Rad Laboratories
  • Cepheid
  • Life Technologies
  • Takara Bio
  • New England Biolabs
  • Illumina
  • Yikang Gene
  • Merck KGaA
  • Promega Corporation

Segment by Type

  • Polymerase Chain Reaction (PCR)
  • Loop Mediated Isothermal Amplification (LAMP)
  • Other

Segment by Application

  • Medical
  • Forensics
  • Paternity
  • Personnel Identification
  • Food safety
  • Other

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Amplification Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Amplification Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Loop Mediated Isothermal Amplification (LAMP)
1.2.4 Other
1.3 Market by Application
1.3.1 Global Gene Amplification Technologies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical
1.3.3 Forensics
1.3.4 Paternity
1.3.5 Personnel Identification
1.3.6 Food safety
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Amplification Technologies Market Perspective (2019-2030)
2.2 Gene Amplification Technologies Growth Trends by Region
2.2.1 Global Gene Amplification Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Amplification Technologies Historic Market Size by Region (2019-2024)
2.2.3 Gene Amplification Technologies Forecasted Market Size by Region (2025-2030)
2.3 Gene Amplification Technologies Market Dynamics
2.3.1 Gene Amplification Technologies Industry Trends
2.3.2 Gene Amplification Technologies Market Drivers
2.3.3 Gene Amplification Technologies Market Challenges
2.3.4 Gene Amplification Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Amplification Technologies Players by Revenue
3.1.1 Global Top Gene Amplification Technologies Players by Revenue (2019-2024)
3.1.2 Global Gene Amplification Technologies Revenue Market Share by Players (2019-2024)
3.2 Global Gene Amplification Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Amplification Technologies Revenue
3.4 Global Gene Amplification Technologies Market Concentration Ratio
3.4.1 Global Gene Amplification Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Amplification Technologies Revenue in 2023
3.5 Gene Amplification Technologies Key Players Head office and Area Served
3.6 Key Players Gene Amplification Technologies Product Solution and Service
3.7 Date of Enter into Gene Amplification Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Amplification Technologies Breakdown Data by Type
4.1 Global Gene Amplification Technologies Historic Market Size by Type (2019-2024)
4.2 Global Gene Amplification Technologies Forecasted Market Size by Type (2025-2030)
5 Gene Amplification Technologies Breakdown Data by Application
5.1 Global Gene Amplification Technologies Historic Market Size by Application (2019-2024)
5.2 Global Gene Amplification Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Amplification Technologies Market Size (2019-2030)
6.2 North America Gene Amplification Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Amplification Technologies Market Size by Country (2019-2024)
6.4 North America Gene Amplification Technologies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Amplification Technologies Market Size (2019-2030)
7.2 Europe Gene Amplification Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Amplification Technologies Market Size by Country (2019-2024)
7.4 Europe Gene Amplification Technologies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Amplification Technologies Market Size (2019-2030)
8.2 Asia-Pacific Gene Amplification Technologies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Amplification Technologies Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Amplification Technologies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Amplification Technologies Market Size (2019-2030)
9.2 Latin America Gene Amplification Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Amplification Technologies Market Size by Country (2019-2024)
9.4 Latin America Gene Amplification Technologies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Amplification Technologies Market Size (2019-2030)
10.2 Middle East & Africa Gene Amplification Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Amplification Technologies Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Amplification Technologies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Gene Amplification Technologies Introduction
11.1.4 Abbott Laboratories Revenue in Gene Amplification Technologies Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 QIAGEN
11.2.1 QIAGEN Company Detail
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Gene Amplification Technologies Introduction
11.2.4 QIAGEN Revenue in Gene Amplification Technologies Business (2019-2024)
11.2.5 QIAGEN Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Gene Amplification Technologies Introduction
11.3.4 Agilent Technologies Revenue in Gene Amplification Technologies Business (2019-2024)
11.3.5 Agilent Technologies Recent Development
11.4 Bayer Corporation
11.4.1 Bayer Corporation Company Detail
11.4.2 Bayer Corporation Business Overview
11.4.3 Bayer Corporation Gene Amplification Technologies Introduction
11.4.4 Bayer Corporation Revenue in Gene Amplification Technologies Business (2019-2024)
11.4.5 Bayer Corporation Recent Development
11.5 Rubicon Genomics
11.5.1 Rubicon Genomics Company Detail
11.5.2 Rubicon Genomics Business Overview
11.5.3 Rubicon Genomics Gene Amplification Technologies Introduction
11.5.4 Rubicon Genomics Revenue in Gene Amplification Technologies Business (2019-2024)
11.5.5 Rubicon Genomics Recent Development
11.6 BD
11.6.1 BD Company Detail
11.6.2 BD Business Overview
11.6.3 BD Gene Amplification Technologies Introduction
11.6.4 BD Revenue in Gene Amplification Technologies Business (2019-2024)
11.6.5 BD Recent Development
11.7 Roche Diagnostics
11.7.1 Roche Diagnostics Company Detail
11.7.2 Roche Diagnostics Business Overview
11.7.3 Roche Diagnostics Gene Amplification Technologies Introduction
11.7.4 Roche Diagnostics Revenue in Gene Amplification Technologies Business (2019-2024)
11.7.5 Roche Diagnostics Recent Development
11.8 BioMerieux
11.8.1 BioMerieux Company Detail
11.8.2 BioMerieux Business Overview
11.8.3 BioMerieux Gene Amplification Technologies Introduction
11.8.4 BioMerieux Revenue in Gene Amplification Technologies Business (2019-2024)
11.8.5 BioMerieux Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Detail
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Gene Amplification Technologies Introduction
11.9.4 Bio-Rad Laboratories Revenue in Gene Amplification Technologies Business (2019-2024)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 Cepheid
11.10.1 Cepheid Company Detail
11.10.2 Cepheid Business Overview
11.10.3 Cepheid Gene Amplification Technologies Introduction
11.10.4 Cepheid Revenue in Gene Amplification Technologies Business (2019-2024)
11.10.5 Cepheid Recent Development
11.11 Life Technologies
11.11.1 Life Technologies Company Detail
11.11.2 Life Technologies Business Overview
11.11.3 Life Technologies Gene Amplification Technologies Introduction
11.11.4 Life Technologies Revenue in Gene Amplification Technologies Business (2019-2024)
11.11.5 Life Technologies Recent Development
11.12 Takara Bio
11.12.1 Takara Bio Company Detail
11.12.2 Takara Bio Business Overview
11.12.3 Takara Bio Gene Amplification Technologies Introduction
11.12.4 Takara Bio Revenue in Gene Amplification Technologies Business (2019-2024)
11.12.5 Takara Bio Recent Development
11.13 New England Biolabs
11.13.1 New England Biolabs Company Detail
11.13.2 New England Biolabs Business Overview
11.13.3 New England Biolabs Gene Amplification Technologies Introduction
11.13.4 New England Biolabs Revenue in Gene Amplification Technologies Business (2019-2024)
11.13.5 New England Biolabs Recent Development
11.14 Illumina
11.14.1 Illumina Company Detail
11.14.2 Illumina Business Overview
11.14.3 Illumina Gene Amplification Technologies Introduction
11.14.4 Illumina Revenue in Gene Amplification Technologies Business (2019-2024)
11.14.5 Illumina Recent Development
11.15 Yikang Gene
11.15.1 Yikang Gene Company Detail
11.15.2 Yikang Gene Business Overview
11.15.3 Yikang Gene Gene Amplification Technologies Introduction
11.15.4 Yikang Gene Revenue in Gene Amplification Technologies Business (2019-2024)
11.15.5 Yikang Gene Recent Development
11.16 Merck KGaA
11.16.1 Merck KGaA Company Detail
11.16.2 Merck KGaA Business Overview
11.16.3 Merck KGaA Gene Amplification Technologies Introduction
11.16.4 Merck KGaA Revenue in Gene Amplification Technologies Business (2019-2024)
11.16.5 Merck KGaA Recent Development
11.17 Promega Corporation
11.17.1 Promega Corporation Company Detail
11.17.2 Promega Corporation Business Overview
11.17.3 Promega Corporation Gene Amplification Technologies Introduction
11.17.4 Promega Corporation Revenue in Gene Amplification Technologies Business (2019-2024)
11.17.5 Promega Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock